Storia in 2 fonti

Bigger, fewer, tougher: the new era of China-US biotech partnerships

China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

scmp.comStai leggendo1 mese fa

China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.

BIO makes China political strategy a top priority as US weighs outbound investment limits; CEO Crowley says biotech may fall under COINS Act.